Improving Access to Renal Transplantation for Underserved Black Communities
Key facts
- Who runs it
- Northwestern University
- Where
- Tampa, United StatesSee the site
- Trial code
- Status
- Withdrawn
- Started
- 1 Apr 2025
- Ended
- 6 May 2025
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- AATAP intervention
- Record updated
- 9 May 2025
- Why it stopped
- Federal funding was no longer viable
Who can take part
- Age
- 18 years to 75 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- self-identify as Black or African American
- 18 to 75 years of age
- have an eGFR < 20 or End Stage Renal Disease Diagnosis
- screen positive for AATAP via the screener (for poor health literacy or poor medical adherence or psychosocial concerns)
- medically eligible to begin transplant evaluation process determined by transplant team
Who cannot take part
- participants who have previously received a transplant
- children less than 18 years old
- other racial groups
- pregnant women
- participants who screen negative on the screener
Where in United States
- Tampa General HospitalTampa, United StatesNo longer taking part
About the trial
What the trial wants to find out
The goal of this clinical trial is to learn whether the African American Transplant Access Program can be successfully replicated at another large kidney transplant program. The main questions it aims to answer are:
Read full original descriptionShow less
Does the AATAP intervention increase the number of Black patients who are listed for kidney transplant? Does the AATAP intervention have an effect on Black patient self-efficacy and trust in care team?
Researchers will compare kidney transplant listing status after 12 months of patients in the AATAP intervention to usual care patients to see if the AATAP program increases the number of patients listed for transplant.
The 2 groups in the trial
- AATAP (intervention) ArmTreatment being tested
One clinic visit with all transplant providers, racially concordant care team, dedicated social worked. This will incorporate: Cultural congruency, trust, health literacy and psychological support. Questionnaires also to be administered
Treatment: AATAP intervention
- Standard of Care (Control) ArmNo study treatment, for comparison
Separate visits with nephologist, surgeons and social worker. This arm will follow common standard of care at the site. Questionnaires also to be administered
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 9 May 2025